Luqing Wei

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Interleukins in community-acquired pneumonia: from biomarkers to precision medicine.

Interleukins in community-acquired pneumonia: from biomarkers to precision medicine.

Journal: Frontiers in immunology

Published: December 24, 2025

Add-On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin-Treated Mice and Patients With Pulmonary Fibrosis.

Add-On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin-Treated Mice and Patients With Pulmonary Fibrosis.

Journal: Respirology (Carlton, Vic.)

Published: September 21, 2024

Diagnosis of mycobacterium avium complex infection utilizing metagenomics next-generation sequencing: a case report.

Diagnosis of mycobacterium avium complex infection utilizing metagenomics next-generation sequencing: a case report.

Journal: Frontiers in medicine

Published: June 25, 2023

Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axis.

Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axis.

Journal: European journal of pharmacology

Published: May 04, 2023

Effect of extracellular adenosine triphosphate hydrolysis by apyrase on bleomycin-induced circulating and alveolar mononuclear phagocyte activation and lung inflammation.

Effect of extracellular adenosine triphosphate hydrolysis by apyrase on bleomycin-induced circulating and alveolar mononuclear phagocyte activation and lung inflammation.

Journal: Chinese medical journal

Published: March 09, 2023

FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis.

FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis.

Journal: International journal of biological sciences

Published: October 24, 2022

Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice.

Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice.

Journal: BMC pulmonary medicine

Published: September 07, 2022

Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway.

Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway.

Journal: Journal of cellular and molecular medicine

Published: July 26, 2022

Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.

Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.

Journal: International immunopharmacology

Published: July 09, 2022

Vorapaxar proven to be a promising candidate for pulmonary fibrosis by intervening in the PAR1/JAK2/STAT1/3 signaling pathway-an experimental in vitro and vivo study.

Vorapaxar proven to be a promising candidate for pulmonary fibrosis by intervening in the PAR1/JAK2/STAT1/3 signaling pathway-an experimental in vitro and vivo study.

Journal: European journal of pharmacology

Published: June 19, 2022

Knockdown of Kruppel like factor 4 (KLF4) promotes RAW264.7 macrophages into M1 polarization

Knockdown of Kruppel like factor 4 (KLF4) promotes RAW264.7 macrophages into M1 polarization

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: September 24, 2020

Effects of Qizhukangxian granules on idiopathic pulmonary fibrosis: a randomized, double blind, placebo-controlled and multicenter clinical pilot trial.

Effects of Qizhukangxian granules on idiopathic pulmonary fibrosis: a randomized, double blind, placebo-controlled and multicenter clinical pilot trial.

Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan

Published: August 04, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026